Brussels Metropolitan Area
I am a dynamic, enthusiastic and results driven professional with a strong scientific and economic background (obtained both a PhD and MBA), skilled in providing strategic, tactical, financial and operational guidance. I have demonstrated leadership in coaching and leading teams, managing budgets, developing launch strategies and entering new markets. I developed excellent skills in the planning, execution and critical analysis of scientific and market data. As I have a combined scientific and economic background, I am able to leverage my scientific expertise to support business strategies and tactics. I have strong communication and problem solving skills, as well as writing and presentation competencies. Accomplishments: - PhD in Biomedical Sciences - Master in Business Administration - Multidisciplinary experience in academia and industry - Coaching and leading teams - Scientific and economic expertise with a focus on strategy, innovation and disruption - Obtained multiple scientific awards, grants and fellowships - International mobility: working experience in Europe and United States - Teaching and supervising students
• Strategic direction: Design and implmentation of organizational strategy; translation into a tactical plan with clear KPI's • Financial leadership: Full P&L oversight, strategic financial planning, accounting, budget management, payments, annual accounts, VAT, optimizing cash flow and investment for long-term sustainability; fianancial controlling and reporting; financial modelling for risk management. • Developing new business model designs, including defining price points, service levels, and legal structure, leading to sustainable revenue streams • Clinical portfolio oversight: Manage the financial and operational lifecycle of oncology clinical trials (Phase 1–4), providing oversight on trial design, feasibility analysis, budget calculation, and complex contract negotiations/milestone payments. • Innovation & digital transformation: Scout, evaluate, and implement digital tools to automate patient-to-trial matching and translate complex scientific data into accessible content. • Operational excellence: Lead cross-functional "silo-breaking" projects to align science, finance, and marketing; develop real-time operational dashboards to analyze cost-efficiencies and performance metrics. • Marketing & communication: Direct brand-building and omnichannel marketing strategies to increase international brand awareness, utilizing a differentiated value proposition to support organizational expansion. • Stakeholder diplomacy: Act as an Executive Committee member and global ambassador, cultivating partnerships with international researchers, hospitals, biotech, and regulatory bodies. • Facilities & vendor management: Oversee facilities management and the identification/selection of third-party vendors, ensuring rigorous contract management and performance evaluation.
• Team leadership: Coached and developed a high-performing team of Medical (Innovation) Managers & Medical Science Liaisons; pioneered "medical bootcamps" to enhance business and digital acumen. • Launch & lifecycle management: Orchestrated cross-functional (pre-)launch strategies for acute, chronic, and rare disease assets, delivering market leadership and revenue growth. Full life cycle management of in-market brands. • Medical innovation: Proactively designed a "Medical Innovation Manager" role to scout digital methodologies that solve operational bottlenecks; developed HCP adoption ladders; a new field insights tool; personalized customer journeys: upskilled omnichannel. • Medical education: Developed innovative medical education programs in several domains, moving beyond traditional formats to impactful, blended learning, thereby boosting HCP attendance. • Patient-centric programs: Implemented value-creating hospital projects to improve different elements of the patient journey. • Broad stakeholder engagement with healthcare professionals, key opinion leaders, hospitals, payors, professional organisations, patient organisations and CROs. • Evidence generation (RWE): Drove Real-World Evidence (RWE) projects to close clinical gaps and support complex reimbursement dossiers. • Clinical development: Managing local medical field contributions to clinical trials (phase 2-4), investigator-driven studies and medical need programs • Commercial partnership: Provided strategic input for public hospital tenders and commercial toolkits, ensuring scientific accuracy was aligned with commercial objectives. • Cross-functional support: Providing strategic and operational input to market access, regulatory and clinical development. • Compliance & medical review: Performed final medical review and approval for all medical and commercial materials, ensuring strict adherence to regulatory standards and ethics. • Budget oversight: Maintained full medical budget responsibility.
• Team leadership: Coached and developed a high-performing team of medical and clinical advisors and medical science liaisons; Proven ability to build culture and retain talent, achieving high retention and focus on team development. • Strategy creation: Co-led cross-functional (pre-)launch strategies for successful entries in BeLux market. • Tactical execution: Translated global medical strategies into winning local tactical plans, focusing on patient-centric partnerships and high-impact KOL engagement plans. • Early-asset medical strategy: Led early-asset strategy and market preparation for pipeline drugs, focusing on competitive intelligence, stakeholder mapping, patient journeys and unmet need analysis. • Medical excellence: Mapped patient pathways to identify leakage points and evidence gaps; educated a cross-functional team of 30+ people on CRM clinical data and performed in-field training. • Stakeholder engagement: HealthCare Professionals, Key Opinion Leaders, hospitals, payors, professional organisations, patient organisations and CROs. • RWE: Set-up innovative, large, national public-private collaborative real-world evidence partnership. • Clinical operations support: Acted as the senior point of escalation for clinical study investigators; oversaw all local medical contributions to the global clinical program. • Budget oversight: Maintained full medical budget responsibility (manpower and operational) with a consistent track record of <5% budget variance. • Compliance: Perform medical reviews and approvals of all medical and commercial materials.
• Scientific communication: Provided high-level scientific expertise to Key Opinion Leaders (KOLs) and Patient Advocacy Groups (PAGs); delivered data presentations at major symposia and internal trainings. • Field-based insights: Systematically collected field insights from HCPs and healthcare organizations to inform brand team strategies and marketing requirements. • Medical activities management: Managed the planning, execution, and budget of all non-promotional medical activities, including the organization of advisory boards and symposia. • Cross-functional support: Provided scientific backbone for marketing campaigns and regulatory/market access submissions, ensuring data accuracy and therapeutic impact. • Grant evaluation: Evaluated incoming requests for investigator-initiated studies and educational grants, ensuring alignment with therapeutic area priorities and compliance. • Clinical development: Provided input on feasibility, sites and investigators selection of clinical trials.
Research focus: the unraveling of new pathways and mechanisms involved in the improvement of glucose metabolism by weight loss induced by either diet or gastric bypass surgery Responsibilities: grant writing, project supervision and execution, supervision of master and PhD students Expertise: type 2 diabetes, obesity, diet, gastric bypass surgery, insulin resistance, RNA-seq, ChIP-Seq, non-coding RNA, histone modifications, epigenetics, silencing tools (CRISPR, LNA, siRNA), metabolic phenotyping (glucose and insulin tolerance tests, hyperinsulinemic euglycemic clamps, metabolic cages)